Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-27

Clinical Trial Update: Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes a double-blind Phase 2/3 study of duloxetine in chronic fatigue syndrome, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)
  • Duloxetine (DULOXETINE)

Snippet

Sponsor: University of Cincinnati | Conditions: Fatigue Syndrome, Chronic | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-07-27